PMC10164376_01
Serum glucose and insulin dynamics over the time course of treatment with alpelisib, patient #1/. The x-axis, reflecting timeline is non-linear, black vertical lines indicate months. Periods under active alpelisib treatment are shaded gray. Medications affecting glycemic control are depicted chronologically (lower panel).
BTT-17-61-g0001.jpg
PMC10164376_01_BTT-17-61-g0001.jpg
f0001
Serum glucose and insulin dynamics over the time course of treatment with alpelisib are depicted in Figure 1, alongside a medication panel deploying chronologically administration of all agents affecting glycemic control.
PMC10164376_02
Serum glucose and insulin dynamics over the time course of treatment with alpelisib, patient #2. Periods under active alpelisib treatment are shaded gray. Medications affecting glycemic control are depicted chronologically (lower panel).
BTT-17-61-g0002.jpg
PMC10164376_02_BTT-17-61-g0002.jpg
f0002
Trajectories of glucose and insulin levels are depicted in Figure 2.
PMC10164376_03
PMC10164376_04